Goldman Sachs’s Sorrento Therapeutics, Inc. SRNE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q1 | – | Sell |
-2,773,811
| Closed | -$2.46M | – | 5433 |
|
2022
Q4 | $2.46M | Sell |
2,773,811
-236,329
| -8% | -$209K | ﹤0.01% | 3141 |
|
2022
Q3 | $4.73M | Buy |
3,010,140
+1,070,161
| +55% | +$1.68M | ﹤0.01% | 2677 |
|
2022
Q2 | $3.9M | Buy |
1,939,979
+362,913
| +23% | +$730K | ﹤0.01% | 2877 |
|
2022
Q1 | $3.68M | Buy |
1,577,066
+944,285
| +149% | +$2.2M | ﹤0.01% | 3042 |
|
2021
Q4 | $2.94M | Buy |
632,781
+35,015
| +6% | +$163K | ﹤0.01% | 3210 |
|
2021
Q3 | $4.56M | Buy |
597,766
+20,023
| +3% | +$153K | ﹤0.01% | 2856 |
|
2021
Q2 | $5.6M | Sell |
577,743
-79,630
| -12% | -$772K | ﹤0.01% | 2698 |
|
2021
Q1 | $5.44M | Sell |
657,373
-1,251,900
| -66% | -$10.4M | ﹤0.01% | 2608 |
|
2020
Q4 | $13M | Buy |
1,909,273
+737,721
| +63% | +$5.04M | ﹤0.01% | 1876 |
|
2020
Q3 | $13.1M | Buy |
1,171,552
+394,791
| +51% | +$4.4M | ﹤0.01% | 1759 |
|
2020
Q2 | $4.88M | Sell |
776,761
-244,105
| -24% | -$1.53M | ﹤0.01% | 2351 |
|
2020
Q1 | $1.88M | Buy |
1,020,866
+811,409
| +387% | +$1.49M | ﹤0.01% | 2795 |
|
2019
Q4 | $708K | Buy |
209,457
+131,898
| +170% | +$446K | ﹤0.01% | 3496 |
|
2019
Q3 | $166K | Sell |
77,559
-705
| -0.9% | -$1.51K | ﹤0.01% | 3957 |
|
2019
Q2 | $209K | Sell |
78,264
-33,890
| -30% | -$90.5K | ﹤0.01% | 3857 |
|
2019
Q1 | $533K | Sell |
112,154
-13,566
| -11% | -$64.5K | ﹤0.01% | 3538 |
|
2018
Q4 | $301K | Sell |
125,720
-130,430
| -51% | -$312K | ﹤0.01% | 3605 |
|
2018
Q3 | $1.13M | Buy |
256,150
+160,147
| +167% | +$705K | ﹤0.01% | 3139 |
|
2018
Q2 | $691K | Sell |
96,003
-376,279
| -80% | -$2.71M | ﹤0.01% | 3374 |
|
2018
Q1 | $2.43M | Buy |
472,282
+439,579
| +1,344% | +$2.26M | ﹤0.01% | 2769 |
|
2017
Q4 | $124K | Buy |
32,703
+26,736
| +448% | +$101K | ﹤0.01% | 3937 |
|
2017
Q3 | $10K | Sell |
5,967
-265,723
| -98% | -$445K | ﹤0.01% | 4235 |
|
2017
Q2 | $543K | Buy |
271,690
+251,078
| +1,218% | +$502K | ﹤0.01% | 3496 |
|
2017
Q1 | $81K | Buy |
20,612
+8,345
| +68% | +$32.8K | ﹤0.01% | 4158 |
|
2016
Q4 | $60K | Sell |
12,267
-390
| -3% | -$1.91K | ﹤0.01% | 4208 |
|
2016
Q3 | $98K | Buy |
12,657
+2,937
| +30% | +$22.7K | ﹤0.01% | 4188 |
|
2016
Q2 | $54K | Buy |
9,720
+1,819
| +23% | +$10.1K | ﹤0.01% | 4262 |
|
2016
Q1 | $43K | Buy |
7,901
+2,857
| +57% | +$15.5K | ﹤0.01% | 4252 |
|
2015
Q4 | $44K | Sell |
5,044
-3,052
| -38% | -$26.6K | ﹤0.01% | 4217 |
|
2015
Q3 | $68K | Sell |
8,096
-9,372
| -54% | -$78.7K | ﹤0.01% | 4271 |
|
2015
Q2 | $308K | Sell |
17,468
-13,232
| -43% | -$233K | ﹤0.01% | 3696 |
|
2015
Q1 | $355K | Buy |
+30,700
| New | +$355K | ﹤0.01% | 3536 |
|
2014
Q3 | – | Sell |
-15,167
| Closed | -$102K | – | 4637 |
|
2014
Q2 | $102K | Buy |
+15,167
| New | +$102K | ﹤0.01% | 4180 |
|